October 26, 2020
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
MONDAY, Oct. 26, 2020 (HealthDay News) — Drugmakers AstraZeneca and Johnson & Johnson are ready to resume paused COVID-19 vaccine trials after health scares, CNN reported. The AstraZeneca trial was stopped in early September, and the Johnson & Johnson trial was paused earlier this month. The U.S. Food and Drug Administration authorized the restart after...
Hospitals Straining Under Weight of Surging COVID-19 Case Counts
MONDAY, Oct. 26, 2020 (HealthDay News) — As the United States witnessed record-breaking daily COVID-19 case counts over the weekend, public health experts warned that hospitals may soon reach a breaking point. More than 41,000 COVID-19 patients are hospitalized across the country, a 40 percent rise in the past month, The New York Times reported....
Mental Health Issues Prevalent in Quarantining Students
MONDAY, Oct. 26, 2020 (HealthDay News) — Among university students confined during the COVID-19 pandemic, the prevalence of mental health issues was high, according to a study published online Oct. 23 in JAMA Network Open. Marielle Wathelet, M.D., from Centre Hospitalier Universitaire de Lille in France, and colleagues collected data from April 17 to May...
ASN: Finerenone May Slow Progression in CKD With T2DM
MONDAY, Oct. 26, 2020 (HealthDay News) — Finerenone results in a lower risk for chronic kidney disease (CKD) progression in patients with CKD and type 2 diabetes, according to a study published online Oct. 23 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of...
COVID-19 Pandemic Challenges Osteoporosis Management
MONDAY, Oct. 26, 2020 (HealthDay News) — The COVID-19 pandemic may have negatively impacted osteoporosis management, according to a study published online Oct. 14 in Osteoporosis International. Eugene V. McCloskey, M.D., from the University of Sheffield in the United Kingdom, and colleagues quantified the global impact of the COVID-19 pandemic on management of osteoporosis by...
COVID-19-Related Death Up for Adults With Down Syndrome
MONDAY, Oct. 26, 2020 (HealthDay News) — Adults with Down syndrome have an increased risk for COVID-19-related death, according to a research letter published online Oct. 21 in the Annals of Internal Medicine. Ashley Kieran Clift, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues examined Down syndrome as a risk factor...
Factors ID'd for Strong Antibody Response in COVID-19
MONDAY, Oct. 26, 2020 (HealthDay News) — Sex, age, and severity of disease can predict increased antibody response in COVID-19 survivors, according to a study published recently in the Journal of Clinical Investigation. Sabra L. Klein, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues evaluated humoral immune response using...